[PDF][PDF] Prostate cancer epidemiology

AW Hsing, AP Chokkalingam - Front Biosci, 2006 - Citeseer
[Frontiers in Bioscience 11, 1388-1413, May 1, 2006] 1388 Prostate cancer epidemiology Ann
W. Hsing 1 and Anand P. Chokkalingam Page 1 [Frontiers in Bioscience 11, 1388-1413, May 1 …

The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer

EA Platz, E Giovannucci - The Journal of steroid biochemistry and …, 2004 - Elsevier
The purpose of this review is to discuss the epidemiologic literature on the association of sex
steroid hormones and components of their signaling and metabolic pathways with prostate …

Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis

L Zuccolo, R Harris, D Gunnell, S Oliver, JA Lane… - … Biomarkers & Prevention, 2008 - AACR
Background: Height, a marker of childhood environmental exposures, is positively
associated with prostate cancer risk, perhaps through the insulin-like growth factor system …

[HTML][HTML] Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes

CM Zeigler-Johnson, E Spangler, M Jalloh… - The Canadian journal …, 2008 - ncbi.nlm.nih.gov
Methods A review of the literature was undertaken to evaluate the role that genetic
susceptibility may play in prostate cancer etiology and outcomes, with a particular emphasis …

Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer☆

MT Salam, G Ursin, EC Skinner, T Dessissa… - … Oncology: Seminars and …, 2005 - Elsevier
The prostate gland is an androgen-dependent, and polymorphisms in androgen synthesis
gene steroid 5-α reductase type II (SRD5A2) may be associated with benign prostatic …

Steroid 5-α-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review

J Li, RJ Coates, M Gwinn… - American journal of …, 2010 - academic.oup.com
Abstract Steroid 5-α-reductase type 2 (SRD5a2) is a critical enzyme in androgen
metabolism. Two polymorphisms in the SRD5a2 gene, V89L (rs523349) and A49T …

Genetic variation: effect on prostate cancer

TM Sissung, DK Price, M Del Re, AM Ley… - … et Biophysica Acta (BBA …, 2014 - Elsevier
The crucial role of androgens in the development of prostate cancer is well established. The
aim of this review is to examine the role of constitutional (germline) and tumor-specific …

Genetic polymorphisms and prostate cancer risk

A Gsur, E Feik, S Madersbacher - World journal of urology, 2004 - Springer
The identification of common genetic polymorphisms that influence susceptibility to PC
would allow an early risk assessment with earlier and therefore potentially more effective …

CYP17, SRD5A2, CYP1B1, and CYP2D6 Gene Polymorphisms with Prostate Cancer Risk in North Indian Population

RC Sobti, K Onsory, AI Al-Badran, P Kaur… - DNA and cell …, 2006 - liebertpub.com
To investigate the involvement of the CYP17, SRD5A2, CYP1B1, and CYP2D6 variants with
prostate cancer, a case–control study of 100 patients and an equal number of age-matched …

Reducing prostate cancer morbidity and mortality in African American men: issues and challenges.

RA Jones, SM Underwood… - Clinical Journal of …, 2007 - search.ebscohost.com
Prostate cancer is the most commonly diagnosed cancer in men in the United States. It
disproportionately affects African American men when compared to other ethnic groups …